4-(aminomethyl)-1-[3-(3-chlorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]piperidin-4-ol;benzyl N-[[1-[3-(3-chlorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-hydroxypiperidin-4-yl]methyl]carbamate;6-chloro-3-(3-chlorophenyl)-2H-pyrazolo[3,4-b]pyrazine
C53H50Cl4N16O4 — CID 159391537
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-(aminomethyl)-1-[3-(3-chlorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]piperidin-4-ol;benzyl N-[[1-[3-(3-chlorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-hydroxypiperidin-4-yl]methyl]carbamate;6-chloro-3-(3-chlorophenyl)-2H-pyrazolo[3,4-b]pyrazine
4-(aminomethyl)-1-[3-(3-chlorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]piperidin-4-ol;benzyl N-[[1-[3-(3-chlorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-hydroxypiperidin-4-yl]methyl]carbamate;6-chloro-3-(3-chlorophenyl)-2H-pyrazolo[3,4-b]pyrazine (PubChem CID 159391537) has the molecular formula C53H50Cl4N16O4 and a molecular weight of 1116.90 g/mol. Its IUPAC name is 4-(aminomethyl)-1-[3-(3-chlorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]piperidin-4-ol;benzyl N-[[1-[3-(3-chlorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-hydroxypiperidin-4-yl]methyl]carbamate;6-chloro-3-(3-chlorophenyl)-2H-pyrazolo[3,4-b]pyrazine.
Molecular Properties
| Compound Name | 4-(aminomethyl)-1-[3-(3-chlorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]piperidin-4-ol;benzyl N-[[1-[3-(3-chlorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-hydroxypiperidin-4-yl]methyl]carbamate;6-chloro-3-(3-chlorophenyl)-2H-pyrazolo[3,4-b]pyrazine |
|---|---|
| PubChem CID | 159391537 |
| Molecular Formula | C53H50Cl4N16O4 |
| Molecular Weight | 1116.90 g/mol |
| Exact Mass | 1114.30 |
| IUPAC Name | 4-(aminomethyl)-1-[3-(3-chlorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]piperidin-4-ol;benzyl N-[[1-[3-(3-chlorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-hydroxypiperidin-4-yl]methyl]carbamate;6-chloro-3-(3-chlorophenyl)-2H-pyrazolo[3,4-b]pyrazine |
| SMILES | Clc1cccc(-c2[nH]nc3nc(Cl)cnc23)c1.NCC1(O)CCN(c2cnc3c(-c4cccc(Cl)c4)[nH]nc3n2)CC1.O=C(NCC1(O)CCN(c2cnc3c(-c4cccc(Cl)c4)[nH]nc3n2)CC1)OCc1ccccc1 |
| InChI | InChI=1S/C25H25ClN6O3.C17H19ClN6O.C11H6Cl2N4/c26-19-8-4-7-18(13-19)21-22-23(31-30-21)29-20(14-27-22)32-11-9-25(34,10-12-32)16-28-24(33)35-15-17-5-2-1-3-6-17;18-12-3-1-2-11(8-12)14-15-16(23-22-14)21-13(9-20-15)24-6-4-17(25,10-19)5-7-24;12-7-3-1-2-6(4-7)9-10-11(17-16-9)15-8(13)5-14-10/h1-8,13-14,34H,9-12,15-16H2,(H,28,33)(H,29,30,31);1-3,8-9,25H,4-7,10,19H2,(H,21,22,23);1-5H,(H,15,16,17) |
| InChIKey | LMEFXAJDXRRGCD-UHFFFAOYSA-N |
| XLogP | 9.22 |
| TPSA | 274.67 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 16 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 77 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1116.90 |
| LogP ≤ 5 | 9.22 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 16 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159391537 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.